New Delivery Strategy Based on Magnetic Nanoparticles for Disease Treatment

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".

Deadline for manuscript submissions: 30 November 2024 | Viewed by 161

Special Issue Editors


E-Mail Website
Guest Editor
Department of Radiology and Biomedical Imaging, Yale University, New Haven, CT 06519, USA
Interests: magnetic nanoparticle; drug delivery systems; theranosis; brain cancer; MRI
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Radiology and Biomedical Imaging, Yale University, New Haven, CT 06519, USA
Interests: lipid nanoparticles; liposomes; MRI; superparamagnetic iron oxide (SPIO); drug delivery, ischemic stroke, cancer; polymeric nanoparticles

Special Issue Information

Dear Colleagues,

Drug delivery using magnetic nanoparticles (MNPs) represents a cutting-edge approach in medical therapeutics, offering precision and efficiency in targeting specific disease sites. These nanoparticles can be manipulated using external magnetic fields to direct them to specific sites within the body, enhancing the precision of drug delivery and minimizing systemic side effects. The surface of MNPs can also be functionalized with various ligands, antibodies, or peptides to enhance their specificity and interaction with diseased cells, further improving the efficiency of drug delivery. Additionally, MNPs can be utilized for diagnostic purposes through magnetic resonance imaging (MRI), allowing for real-time monitoring of the delivery process. The dual functionality of MNPs in therapy and diagnostics, often referred to as theranostics, presents a promising avenue for the development of personalized medicine, ensuring that treatments are not only more effective but also safer for patients. We invite the submission of research and review articles on the topic of magnetic nanoparticles (MNPs) for disease treatment. This Special Issue delves into innovative strategies for employing magnetic nanoparticles in medical treatments. It addresses their synthesis and functionalization for targeted delivery, with a particular focus on advancements in size, shape, and surface modifications to enhance biocompatibility.

Dr. Sandeep K. Mishra
Dr. Samuel Maritim
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nanoparticle with magnetic core and drug loading capability
  • magnetic contrast agents in Magnetic Resonance Imaging (MRI) and Magnetic Particle Imaging (MPI)
  • magnetic nanoparticle as hyperthermia agents for cancer tumor therapy
  • magnetic vectors which can be directed by magnetic field for targeted drug delivery
  • magnetic nanoparticles conjugated with drugs, ligands, or antibodies for specific delivery
  • magnetic nanoparticle designs to obtain medical breakthroughs in diagnosis, and drug delivery

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop